Viatris Aktie

7,73 EUR +0,05 EUR +0,68 %

15:48:11

XETRA

8,78 USD -0,08 USD -0,85 %

16:05:25

BTT

Aktien, ETFs, Sparpläne & Kryptos zu Top-Konditionen beim Testsieger von finanztip.de handeln!

JETZT LOSLEGEN

Du hast schon ein ZERO-Konto? Direkt handeln bei ZERO!Bei einem anderen Broker handeln Smartphone

Marktkap.9,14 Mrd. EUR

Div. Rendite3,86%

WKNA2QAME

ISINUS92556V1061

SymbolVTRS

Viatris Aktien News

Sortieren:Datum Meistgelesen

29.05.25PR NewswireViatris Inc. Sued for Securities Law Violations - Contact The Gross Law Firm Before June 3, 2025 to Discuss Your Rights - VTRS

28.05.25PR NewswireViatris Inc. (VTRS) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit

28.05.25PR NewswireCLASS ACTION DEADLINE APPROACHING: Berger Montague Advises Viatris (NASDAQ: VTRS) Investors to Inquire About a Securities Fraud Class Action by June 3, 2025

WerbungViatris-Aktie für 0 Euro (zzgl. Spreads) handeln bei finanzen.net zero

27.05.25PR NewswireViatris Announces Launch of First Clozapine Orally Disintegrating Tablet (ODT) in Canada

22.05.25PR NewswireViatris to Participate in Upcoming Investor Conferences

22.05.25PR NewswireViatris Inc. Securities Fraud Class Action Lawsuit Pending: Contact The Gross Law Firm Before June 3, 2025 to Discuss Your Rights - VTRS

20.05.25PR NewswireINVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Viatris Inc. of Class Action Lawsuit and Upcoming Deadlines - VTRS

19.05.25PR NewswireVTRS Investors Have Opportunity to Lead Viatris Inc. Securities Fraud Lawsuit

17.05.25PR NewswireVIATRIS SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Viatris Inc. - VTRS

16.05.25PR NewswireShareholders that lost money on Viatris Inc.(VTRS) should contact Levi & Korsinsky about pending Class Action - VTRS

15.05.25finanzen.netFreundlicher Handel: S&P 500 am Donnerstagnachmittag freundlich

14.05.25PR NewswireViatris Inc. (VTRS) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit

12.05.25PR NewswireVTRS Investors Have Opportunity to Lead Viatris Inc. Securities Fraud Lawsuit

12.05.25PR NewswireINVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Viatris Inc. of Class Action Lawsuit and Upcoming Deadlines - VTRS

10.05.25finanzen.netViatris präsentierte Quartalsergebnisse

10.05.25PR NewswireVIATRIS SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Agains...

08.05.25BenzingaViatris Discloses Positive Data From 2 Drugs In Earnings Report, Stock Soars

08.05.25finanzen.netNYSE-Handel: S&P 500-Börsianer greifen nachmittags zu

08.05.25ZacksViatris Q1 Earnings and Revenues Beat Estimates, Stock Gains

08.05.25finanzen.netZuversicht in New York: S&P 500 am Donnerstagmittag mit grünem Vorzeichen

08.05.25finanzen.netOptimismus in New York: S&P 500 bewegt sich zum Start im Plus

08.05.25ZacksViatris (VTRS) Reports Q1 Earnings: What Key Metrics Have to Say

08.05.25ZacksViatris (VTRS) Beats Q1 Earnings and Revenue Estimates

08.05.25PR NewswireViatris Reports First Quarter 2025 Results and Reaffirms 2025 Outlook

08.05.25PR NewswireViatris Announces Positive Results from Phase 3 Study of Investigational XULANE LO™ Low Dose Patch for Birth Control in Women of Childbearing Potential

08.05.25PR NewswireViatris Announces Positive Top-Line Results from Two Pivotal Phase 3 Studies of Novel Fast-Acting Meloxicam (MR-107A-02) for the Treatment of Moderate-to-Severe Acute Pain

08.05.25PR NewswireThe Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of June 3, 2025 in Viatris Inc. Lawsuit - VTRS

07.05.25PR NewswireViatris Announces Quarterly Dividend

07.05.25finanzen.netAusblick: Viatris gibt Ergebnis zum abgelaufenen Quartal bekannt

06.05.25PR NewswireINVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Viatris Inc. of Class Action Lawsuit and Upcoming Deadlines - VTRS

06.05.25PR NewswireVTRS Investors Have Opportunity to Lead Viatris Inc. Securities Fraud Lawsuit

05.05.25PR NewswireViatris Announces Appointments of Frank D'Amelio and Michael Severino, M.D., to the Company's Board of Directors

05.05.25ZacksUnveiling Viatris (VTRS) Q1 Outlook: Wall Street Estimates for Key Metrics

02.05.25ZacksViatris Q1 Earnings Release: What's in Store for the Stock?

01.05.25ZacksAnalysts Estimate Viatris (VTRS) to Report a Decline in Earnings: What to Look Out for

01.05.25PR NewswireJune 3, 2025 Deadline: Contact The Gross Law Firm to Join Class Action Suit Against VTRS

28.04.25PR NewswireVTRS Investors Have Opportunity to Lead Viatris Inc. Securities Fraud Lawsuit with the Schall Law Firm

25.04.25PR NewswireViatris to Present at the BofA Securities 2025 Healthcare Conference

24.04.25PR NewswireSHAREHOLDER ALERT: Berger Montague Reminds Viatris (NASDAQ: VTRS) Investors of Class Action Lawsuit Deadline

23.04.25finanzen.netErste Schätzungen: Viatris informiert über die jüngsten Quartalsergebnisse

Viatris News

Viatris News: auf dieser Seite finden Sie alle Viatris News und Nachrichten zur Viatris Aktie. Dies beinhaltet die Agentur-Feeds auf finanzen.net, aber auch Viatris News auf einer Vielzahl externer Seiten. Externe Links sind am entsprechenden Link-Symbol zu erkennen. Um Viatris News auf externen Seiten zu lesen, folgen Sie einfach dem entsprechenden Link.